Solésence Reports Third Quarter 2025 Financial Results

Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations

ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025.

Read more at globenewswire.com